Randomised controlled trial of fish oil supplement to treat cancer cachexia

A. Dewey, B. Higgins, C. Baughan, R. Stores, Taraneh Dean, Sally Kilburn

Research output: Contribution to journalArticle

Abstract

Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.
Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalBAOJ Palliative medicine
Volume1
Issue number1
Publication statusPublished - 24 Apr 2015

Fingerprint

Cachexia
Fish Oils
Randomized Controlled Trials
Neoplasms
Eicosapentaenoic Acid
Survival
Omega-3 Fatty Acids
Weight Loss
Quality of Life
Population

Bibliographical note

© 2015 Dewey A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Cite this

Dewey, A., Higgins, B., Baughan, C., Stores, R., Dean, T., & Kilburn, S. (2015). Randomised controlled trial of fish oil supplement to treat cancer cachexia. BAOJ Palliative medicine, 1(1), 1-8.
Dewey, A. ; Higgins, B. ; Baughan, C. ; Stores, R. ; Dean, Taraneh ; Kilburn, Sally. / Randomised controlled trial of fish oil supplement to treat cancer cachexia. In: BAOJ Palliative medicine. 2015 ; Vol. 1, No. 1. pp. 1-8.
@article{1bdd81b9608b4b23be0942e5378dc19b,
title = "Randomised controlled trial of fish oil supplement to treat cancer cachexia",
abstract = "Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.",
author = "A. Dewey and B. Higgins and C. Baughan and R. Stores and Taraneh Dean and Sally Kilburn",
note = "{\circledC} 2015 Dewey A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",
year = "2015",
month = "4",
day = "24",
language = "English",
volume = "1",
pages = "1--8",
journal = "BAOJ Palliative medicine",
number = "1",

}

Dewey, A, Higgins, B, Baughan, C, Stores, R, Dean, T & Kilburn, S 2015, 'Randomised controlled trial of fish oil supplement to treat cancer cachexia', BAOJ Palliative medicine, vol. 1, no. 1, pp. 1-8.

Randomised controlled trial of fish oil supplement to treat cancer cachexia. / Dewey, A.; Higgins, B.; Baughan, C.; Stores, R.; Dean, Taraneh; Kilburn, Sally.

In: BAOJ Palliative medicine, Vol. 1, No. 1, 24.04.2015, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Randomised controlled trial of fish oil supplement to treat cancer cachexia

AU - Dewey, A.

AU - Higgins, B.

AU - Baughan, C.

AU - Stores, R.

AU - Dean, Taraneh

AU - Kilburn, Sally

N1 - © 2015 Dewey A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2015/4/24

Y1 - 2015/4/24

N2 - Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.

AB - Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.

M3 - Article

VL - 1

SP - 1

EP - 8

JO - BAOJ Palliative medicine

JF - BAOJ Palliative medicine

IS - 1

ER -

Dewey A, Higgins B, Baughan C, Stores R, Dean T, Kilburn S. Randomised controlled trial of fish oil supplement to treat cancer cachexia. BAOJ Palliative medicine. 2015 Apr 24;1(1):1-8.